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Abstract
Numerous studies showed the importance of skeletal muscle plasma membrane
(sarcolemma) in the control of skeletal muscle biology. The emphasis in this review
is on the sarcolemmal bioactive lipids decisive for survival, proliferation, differentia‐
tion, and function of skeletal muscle cells with the particular concern on muscle stem
cells (resident satellite cells, RSC) responsible for muscle regeneration. Nowadays, it
is obvious that cholesterol (CHOL), basic component of the lipid rafts (LR) through
the control of assembled dystrophin–glycoprotein complexes (DGC), directs muscle
fiber contractile properties. Another phospholipid, phosphatidylserine (PS), is a
component of the inner plasma membrane leaflet, even though it allows the fusion of
myoblasts when exteriorized. Sphingolipids, such as ceramide, sphingosine, sphin‐
gosine-1-phosphate, and ganglioside GM3, are important signaling molecules in the
charge of RSC activation, their motility, and commitment to particular lineage
(myoblasts and myofibroblasts). Phosphoinositides and phosphatidylinositol-4,5-
biphosphate (PIP2) specifically establish protoplasmic platforms for protein interac‐
tions essential for cell viability and mitochondrial activity. Additionally, both
prenylation and palmitoylation of certain proteins (i.e., heterotrimeric G proteins)
determine their biological activity in signal transduction from G-protein coupled
receptors (GPCR). Isoprenoids are therefore crucial for the recruitment and metabolic
responses of RSC to physiological and pathological stimuli. Finally, iatrogenic
modifications of sarcolemma with hydroxylamines and their derivatives lead to
increased resistance of muscle cells to apoptotic stimuli and slow progression of some
skeletal muscle dystrophies.
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1. Introduction
Skeletal muscle growth and regeneration is dependent on the activation of mitotically
quiescent resident cells known as skeletal muscle satellite cells (SC) located beneath the basal
lamina (integral part of basement membrane) on the plasma membrane (sarcolemma) of adult
skeletal muscle fibers. Activated by muscle injury including work overload (i.e., weight lifting),
satellite cells proliferate making myogenic precursor cells (myoblasts) that migrate to the site
of injury and after withdrawal from the cell cycle fuse collectively or with damaged fibers. The
fusion process is mediated by plasma membrane proteins, some of which are the receptors for
intermediate of lipid metabolism such as sphingosine 1-phosphate (sphingolipid, S1P). A great
deal of plasma membrane surface and integral proteins at the extracellular site is glycosylated
and prenylated, the processes indispensable for intracellular protein transport (from endo‐
plasmic reticulum to Golgi apparatus, and from trans-Golgi network to the plasma membrane)
as well as for lateral and vertical protein translocation within sarcolemma. In adult skeletal
muscle, the self-renewing capacity of satellite cells contributes to muscle growth, and regen‐
eration-associated hypertrophy as skeletal muscle-specific adaptation to workload. Hypertro‐
phy also occurs in satellite cell-depleted skeletal muscle, although in this case neither increase
in myonuclei in satellite cell-depleted fibers nor the muscle regenerates after BaCl2-induced
severe muscle damage [1]. Accordingly, the biochemistry and structural modifications of
plasma membrane are seemingly indispensable for the commitment of satellite cells and their
progeny of myoblasts to skeletal muscle renewal. In this review, we hypothesized that changes
in the sarcolemmal composition of proteome, glycoproteome, and/or lipidome are the major
determinants of satellite cells and muscle fibers to regenerate skeletal muscle. From the
experiments and clinical observations related to statin-induced myopathy [2–4] as well as the
successful efforts aiming to correct plasma membrane integrity by the modification of skeletal
muscle plasma membrane fluidity, we conclude that closer examination of the plasma
membrane composition and structural organization might shed more light on the molecular
mechanisms of satellite cell commitment to muscle rejuvenation.
2. Skeletal muscle growth and regeneration
Nowadays, it is obvious that skeletal muscle growth and regeneration is firmly linked to the
activity of satellite cells adjacent to extrafusal and intrafusal muscle fibers. Intact skeletal
muscle encloses satellite cells in the quiescent state, with a dense nuclear chromatin (hetero‐
chromatin), fine rim of the cytoplasm, and little organelles. Covered by a thin layer of basement
membrane, the satellite cell rests closely applied to the sarcolemma of the muscle fiber (Figure
1). The notion that satellite cells donate nuclei to a growing or regenerating fiber, one at a time,
is widely known from a half of the century [5]. Although quiescent in normal skeletal muscle,
satellite cells (named by Mauro, [6]) become activated and recruited to the cell cycle when there
is a requirement to increase myonuclear number [7]. In response to signals accompanying
skeletal muscle injury, denervation, exercise, or work overload, the activation reverses the
morphology of satellite cells to lower chromatin density (euchromatin), expanded cytoplasm,
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and additional organelles [8–9]. Several lines of evidence suggest numerous molecules
including hormones, growth factors, cytokines, and reactive species as potent incentives in the
activation of satellite cells, yet it is still not clear how these muscle progenitors become receptive
to the stimuli. Rearrangement of plasma membrane lipids, proteins, and their glycosyl and
lipid conjugates might be considered as possible beginning of satellite cell commencement to
sense some of the signals. Despite great biological and clinical interest, our knowledge of in
vivo N-glycosylation sites – a prerequisite for detailed functional understanding – is still very
limited [10]. Similarly, the conception of plasma membrane lipidome input to sense and
transduce the signals for the activation of satellite cells is limited [11]. Thus, any endeavor
intended to decipher the details and mechanisms hidden behind the dynamic changes of
plasma membrane organization is an attractive approach with promising perspective for
future clinical application in the treatment of skeletal muscle myopathies.
3. Sarcolemma
Plasma membrane in skeletal muscle has several exclusive features related to the structure and
composition as well as unique characteristics of membranoskeleton. Nonetheless, some
properties are fairly common for any membrane as phospholipids spontaneously form lipid
bilayers in aqueous environments due to the amphipathic nature of the molecules with a highly
hydrophobic “tail” (acyl chains) and hydrophilic “head” (glycosyl or phosphatidyl) moieties.
Lipids in membranes are distributed disproportionately accounting for substantial differences
in the extracellular vs. intracellular face of plasma membrane (PM). Anyway, a given mem‐
brane has a stable and specific membrane composition dependent on cell type and organelle,
and any changes are observed only in certain physiological situation or pathological anomaly.
The asymmetry of the external leaflet of PM (exoplasmic) is featured by highly enriched in
choline-containing lipids such as phosphatidylcholine (PC) and sphingomyelin (SM), whereas
the cytoplasmic leaflet (protoplasmic) is rich in phosphatidylethanolamine (PE), phosphati‐
dylserine (PS), and other phospholipids [phosphatidic acid (PA), phosphatidylinositol (PI),
phosphatidylinositol-4-monophosphate (PIP), and phosphatidylinositol-4,5-biphosphate
(PIP2)]. The latter participates in cell signaling. Despite cross-sectional diversity, membranes
posses lateral asymmetry in basal, lateral, and apical regions [12–13]. Lipids are also capable
of displaying different phases under different conditions (mesomorphism). Some lipids,
however, as cone-shaped lysophosphatidylcholine (LPC) or PE can form nonlamellar finite
structures such as spherical micelles or tubular structures in membranes [14]. Nonlamellar
prone lipids are involved in membrane fission and fusion processes with the aim of enzymes
such as scramblases, flippases, and floppases. Finally, intact PM is extremely elastic as it reseals
after mechanical rupture allowing for the separation of cell fragments (i.e., synaptosomes).
As thin (5–10 nm) lipid bilayer in eukaryotes, PM plays several tasks emerging beyond defining
simple cellular boundary. It can organize complex tools for transportation (ion channels,
transport proteins, pumps, and invaginations for macromolecules) or molecular sensing
(receptors, Figure 2). PM is also essential to control intercellular communication (flow of
information) through highly dynamic microdomains acting as platforms for molecule inter‐
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actions. Skeletal muscle cell plasma membrane is specifically adapted to resist consequences
of muscle fiber shortening during contraction. Additionally, sarcolemma periodically invagi‐
Figure 1. Electron micrograph of a typical myonucleus (A) and a muscle satellite cell (B). Muscle satellite cells (S) were
identified by their location inside the basal lamina (arrowheads) and outside the sarcolemma (arrows) and an inde‐
pendent cytoplasm. In contrast, a myonucleus (M) is located inside the sarcolemma of the muscle fiber and does not
contain an independent cytoplasm. Bar, 1 mm., reprinted from Sinha-Hikim et al. 2003 [133].
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nates, giving rise to the transverse tubule (TT) network liable for sensing depolarization by
dihydropyridine receptor (DHP) essential to trigger of calcium flux evoked by activation of
ryanodine receptor (RY). Dystrophin–glycoprotein complex (DGC), also known as dystro‐
phin-associated protein complex (DAC), is embedded in sarcolemma (found in other cell types
such as astrocytes) and plays paramount role in the aforementioned actions (Figure 3). It is
composed of several proteins including, dystrophin (DP), dystrobrevin (DB), syntrophin (SP),
dystroglycans (α- and β-DG), and sarcoglycans (α-, β-, δ-, and γ-SG). These proteins are
assembled in order to transmit lateral force during isotonic twitch. Subsarcolemmal protein
assemblies circumferentially aligned in schedule with the Z-disk or peripheral myofibrils are
also known as costameres (assemblies of costameric proteins, Figure 4). They physically couple
force-generating sarcomeres with the sarcolemma in striated muscle fibers and are thus
considered a pitfall of skeletal muscle, a critical component of striated muscle morphology
which, when compromised, is thought to directly contribute to the development of several
distinct myopathies also termed sarcolemmopathies (Figure 5). Costameric proteins are found
in a cholesterol (CHOL) rich membrane fraction pointing to lipid rafts (LR) as spatial locali‐
zation of DGC [15]. Actually, LR are clustered at the level of DP complex through laminin-
mediated interaction with dystroglycans [16]. Furthermore, CHOL depletion uncouples β-DG
from sarcolemmal domains with related impairment of mechanical activity of skeletal muscle
[17] (Figure 6), whereas DP repeats which interact with membrane lipids strengthen the
sarcolemma providing flexible support to muscle fiber membranes (Figure 7) [18]. Addition‐
ally, DGC spatial organization is vital for physical interface between SP and sodium channels
or neuronal nitric oxide synthase (nNOS), although not at the same time. DGC is regularly
distributed along sarcomeres and aligned mainly with Z-disks to connect actin cytoskeleton
with extracellular matrix (ECM) protein laminin (Figure 8). Laminin together with collagen
IV, fibronectin, perlecan, entactins, agrin, and glycosaminoglycans is a component of basement
membrane. Extrinsic protein β-dystroglycan is the laminin receptor and binds membrane-
spanning (integral) α-dystroglycan that mediates interactions with DP and DB [19]. At the
focal adhesions facing Z-lines, the integrin receptors (α7β1) connect fibronectin/laminin with
actin filaments of sarcomeres (Figure 9). Tallin, vinculin, and paxillin are intermediate
filaments forming a lever that hooks up integrins with thin filaments [20, 21]. Caveolin-3 is the
muscle-specific form of caveolin found mainly as intrinsic (inner leaflet) membrane protein at
the sarcolemma and TT [22]. The functions of caveolin-3, β-DG, DP, and SG are controlled by
cholesterol and sphingolipid concentrations in the lipid rafts and caveolae [17–18, 23]. In
striated muscle, signal transduction through cellular membranes can be regulated by the
interaction of the cytoskeleton with caveolae (C) – caveolin-enriched membrane domains [24].
Mounting evidence demonstrates that lipids themselves regulate the location and activity of
many membrane proteins, as well as defining membrane microdomains (lipid rafts, caveolae,
and coated pits) that serve as spatiotemporal platforms for interacting signaling proteins [11].
Lipid rafts (single lipid raft is approximately 50 nm in diameter) are defined as detergent
insoluble glycolipid (GL)-enriched planar domains (detergent resistant membranes, DRM)
highly enriched in cholesterol (CHOL), SM, glycosphingolipids (GSL), and glycosylphospha‐
tidylinositol (GPI)-anchored proteins. To sum up, membrane lipids are classified into three
major groups: glycerol-based lipids (glycosyl-glycerides and phospholipids), sphingolipids
(SL) with sphingoid-base backbone (SM and GSL), and cholesterol. Similar LR may differ in
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their size (fusion and fission), as well as in the proportions of lipids and proteins, somewhat
modified by pathophysiological processes or nutritional and/or pharmacological interven‐
tions. Caveolae are dissimilar to LR as they are deficient in (GPI)-anchored proteins and poor
in CHOL but rich in caveolins, the structural proteins assembled to stabilize membrane
invaginations [25]. In extreme situations, PM may be subjected to disintegration, protein
misfolding, and aggregation, and finally profound dysfunction causes cell death by necrosis.
How these nanodomains are segregated within plasma membrane is a matter of debate,
although cholesterol molecules establish closeness of PL, GL, GSL, SM, and proteins. Choles‐
terol (alcohol) acts as “glue” with hydroxyl group that combines with the phosphate head of
phospholipids, whereas the hydrophobic steroid section works together with phospholipids
acyl chains. Growing body of evidence points to physicochemical forces (intermolecular forces
including electrostatic interactions, hydrogen bonds, Van der Waals forces, and hydration
forces) which determine asymmetric geometry of membranes both laterally and in cross-
section. Moreover, integral proteins also influence lipid structure in the membrane. One might
bear in mind that according to lipidomics, more than 1000 different lipid forms are to be found
in plasma membrane. To meet the requirements of fluidity, membrane components are also
subject to considerable qualitative and quantitative seasonal changes adjusted by the cell [26].
It is determined by the environmental conditions (i.e., cold vs. heat) but also by needs of
adaptation such as hyperplasia/hypertrophy or resistance to different types of stress (shear
stress, oxidative stress including irradiation). In either case, physicochemical properties of
membranes have to facilitate cell signaling and motility. In turn, cell signaling and motility are
influenced by the glycosylation status of PM proteins, both integral represented by receptors
and peripheral because they are heavily modified on the external leaflet.
Figure 2. Schematic illustration of a biomembrane, depicting membrane lipid asymmetry as well as microdomains en‐
riched in particular lipids and those induced by membrane proteins, reprinted from Escriba et al. [12].
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Figure 3. The dystrophin–glycoprotein complex network. Shown in red are the constituents of the core dystrophin–
glycoprotein complex, which copurify as a highly stable complex from skeletal muscle and which show greatly de‐
creased abundance in dystrophin-deficient muscle. α-Dystroglycan and β-dystroglycan (α-DG, β-DG); the sarcoglycan
complex (SGC); sarcospan (SPN); α-dystrobrevin-2 (α-Db 2); syntrophin (SYN). Also shown are structural proteins that
interact directly with components of the dystrophin–glycoprotein complex, their direct binding partners, and their lo‐
cation within striated muscle cells. Cytokeratins 8 and 19 (K8/K19). Proteins highlighted in blue are present at in‐
creased levels when dystrophin is absent, reprinted from Ervasti 2007 [23].
4. Statins and statin-induced myopathy
Statins, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase reversible inhibitors,
became the most frequently prescribed drugs in modern societies used clinically to improve
the lipid profile of hyperlipidemic patients, thereby decreasing the incidence of primary or
secondary ischemic cardiac events [27–28]. The primary mechanism of action of statins is to
lower CHOL levels by the inhibition of mevalonate formation, the rate limiting step in the
cholesterol biosynthesis [29]. Pleiotropic effects of statins which seem to be independent of the
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inhibiting effect on CHOL formation have also been reported [30–31], although statin-induced
release of nitric oxide (NO) and prostaglandins (PGI2) does not explain side effects of statins
on skeletal muscle cells (NO stimulates myogenesis, while PGI2 inhibits platelet activation).
Even if statins are in general well tolerated and are safe for almost all patients, they were
reported to induce different grades of myopathy in a significant part of the population, ranging
from mild myalgia to morbid rhabdomyolysis [32–33]. There are risk factors for developing
statin-induced myopathy (SIM), the significant component of statin intolerance during statin
treatment, such as advanced age, excessive exercise, and multisystem disease as renal or
hepatic insufficiencies, diabetes, or hypothyroidism [34]. Impaired metabolism of statins,
pharmacokinetic interactions, and genetic effects are all probable causes of statin-induced
Figure 4. Top: Simplified model of two muscle sarcomeres in parallel. The sarcomere is composed of the thin (mostly
actin) filaments, the thick (mostly myosin) filaments, and the giant filamentous molecule titin. The thin filaments are
anchored in the Z-line, where they are cross-linked by α-actinin. The thick filament is centrally located in the sarco‐
mere and constitute the sarcomeric A-band. The myosin heads, or cross-bridges, on the thick filament interact with
actin during activation. Titin spans the half-sarcomeric distance from the Z-line to the M-line, thus forming a third sar‐
comeric filament. In the I-band region, titin is extensible and functions as a molecular spring that develops passive ten‐
sion upon stretch. In the A-band, titin is inextensible due to its strong interaction with the thick filament. Bottom:
Electron microscopy photograph of the ultrastructural organization of sarcomeres in parallel, reprinted from Otten‐
heijm et al. 2008 [134].
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myotoxicity (muscle toxicity), although the molecular mechanism has not yet been elucidated
in full. The most frightening clinical adverse effect is drug-induced rhabdomyolysis (0.1–0.5%
in patients treated with pravastatin) the frequency of which is further increased by coadmi‐
Figure 5. Dystrophin as a molecular shock absorber. Shown is a hypothetical model for how dystrophin may function
to dampen elastic extension during muscle stretch. (I) Relaxed muscle. (II) Muscle stretch imposes forces that uncoil
spring-like elements within repeats 1–10 and 18–24. (III) Electrostatic interaction of basic actin-binding repeats 11–17
with acidic actin filaments dampens extension of the spring-like elements. The “nonspecific” electrostatic interaction
between the basic spectrin repeats and actin filaments is optimal because it does not require a specific orientation for
interaction and would allow sliding between dystrophin and actin. As muscle rapidly shortens during contraction, the
electrostatic interaction of the basic actin-binding repeats with acidic actin filaments would also serve to dampen elas‐
tic recoil, reprinted from Ervasti 2007 [23].
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nistration of fibrates [35]. Reductions in skeletal muscle membrane CHOL were initially
thought to account for the range of myopathic reactions. Additionally, the lowering the
isoprenoid levels has been suggested to contribute to these pathologies as protein prenylation,
and the potential consequences of a generalized insufficiency of this form of protein modifi‐
cation [36] are important for the activity and anchorage of plasma and other membrane
proteins (nuclear envelope, dystrophin–glycoprotein complex, cytoskeletal G-proteins, etc.).
There is growing interest to decipher the molecular mechanism of the statin-induced myopa‐
thy, both by scientific community and pharmaceutical companies. One in three people over
the age of 45 is taking a statin to reduce heart attack risk, the HMG-CoA antagonist with three
orders of magnitude greater affinity to bind and subsequently to inhibit HMG-CoA reductase
activity than that of natural substrate (HMG-CoA). Two in five women taking the statin are
weaker than before, with one in ten reporting they felt “much worse”. As statins became the
most frequently prescribed drugs to prevent cardiovascular crisis alongside with the effort to
pace physical activity, the issue how to protect from statin-induced myalgia, myositis, and rare
cases of rhabdomyolysis is of great concern. In fact, due to muscle toxicity, an estimated 5–
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Figure 6. A model of the effect of membrane cholesterol depletion on the sarcolemmal distribution of β-DG. The sarco‐
lemmal lipid rafts close to the clear opening of the TT-membrane are enriched in cholesterol, GM1 (ganglioside M1),
Cav-3 (caveolin-3), and β-DG (dystroglycan). The schematic diagram illustrates the diminished contact between β-DG
and Dys (dystrophin) in the presence of MβCD (methyl β-cyclodextrin); the β-DG/Dys interaction is essential for later‐
al force transmission. SERCA1 (sarcoplasmic reticulum calcium ATPase) and RyR (ryanodine receptor (SR Ca2+ chan‐
nel)) function normally. SL, sarcolemma; SR, sarcoplasmic reticulum; EM, extracellular matrix; LR, lipid raft; Dys,
dystrophin; SG, sarcoglycan; CSQ, calsequestrin, adapted from Vega-Moreno et al. 2012 [17].
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10% of patients discontinue statin use due to myopathic symptoms. Reports of myositis and
myopathic symptoms increase with increased statin dose [37], with different classes of statins,
or when statins are coupled with other drugs [38], and with exercise [33]. The mechanistic
underpinning of statin myopathy are believed to be multifactorial and partially attributed to
Figure 7. Schematic diagram of the sarcomere and costamere protein complexes of striated muscle cells. Major compo‐
nents of the mature sarcomere and costamere are shown, along with the cytoskeletal and motor filament systems, in
context with the sarcolemma and organelles of syncytial myocytes. Known chaperone or cochaperone molecules are
shown in bold, along with their substrates. Arrows indicate regions where chaperone-mediated protein folding is es‐
sential to incorporate polymeric filament proteins, adapted from Sparrow and Schock 2009 [135], reprinted from
Myhre and Pilgrim 2012 [136].
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the regulatory effects of statins on apoptosis of muscle cells [39] and proliferation [3]. As
skeletal muscle resident satellite cells (RSC) represent physiological reserve of undifferentiated
muscle progenitors, it is obvious that activation followed by proliferation and migration are
crucial in muscle adaptation to mechanical overload and regeneration from injury [40]. Thus,
if statins impair RSC activation these processes could not be initiated. To tackle the problem
of reduced CHOL concentration in plasma membrane and associated changes in the function
of LR in muscle cells seems to be fundamental. The focal point is LR, where changes (bio‐
chemical and morphological) are presumably attributed to the consequences of disturbed cell
signaling. As HMG-CoA reductase activity is ubiquitous, while the side effects of statins are
confined to skeletal muscle, it is suggested that muscle tissue is featured by unique response
to lower CHOL. RSC are targeted by CHOL depletion and the consequences are cumulative
as muscle growth is stopped at the initiation phase (signal transduction). This assumption is
supported by the data obtained from sarcolemma examination (single molecule microscopy
and molecular studies), which demonstrate the isolation and downregulation of LR and the
recruitment of mitochondrial oxidative phosphorylation system during myogenesis [41–42].
CHOL and GSL/SL are also present in the membranes of cellular organelles such as ER and
Figure 8. This figure shows the structure of the costamere and known molecular interactions. Below the membrane
bilayer shown is the intracellular space and above it is the extracellular space. In the intracellular space, the costamere
is attached to the contractile proteins through dystrophins (for the dystrophin glycoprotein complex, DGC), vinculin,
talin, and paxilin (for the integrin complexes; not shown). In the extracellular space, both DGCs and integrin com‐
plexes bind to the components of the basal lamina that is attached to the rest of the extracellular matrix that consists
mostly of fibrillar collagens, reprinted from Voermans et al. 2008 [137].
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Golgi complex (GC). Their role, however, remains obscure as methods to study effects of CHOL
depletion in organelles are limited. The main concern should be placed on the sarcolemma and
mitochondria, since these organelles control both muscle growth and development [43, 44].
5. Statin-induced myopathy and mitochondria
The development of statin-induced rhabdomyolysis is a morbid side effect of HMG-CoA
reductase inhibition, occurring in less than 1 in 1000 statin-treated patients [45]. Even though
occurrence of myopathy in statin-treated individuals has been estimated to range from 1 to
10%. Studies performed on rats confirmed that atorvastatin treatment reduces exercise
capacity manifested by higher fatigability [46]. It is more common in statin users regularly
exercised or statin-treated athletes pointing to the high correlation between the muscle
contractive activity and muscle-associated complications of statin administration. Among
several hypotheses raised to explain the aforementioned causal relationship between statins
and physical exercise, growing body of evidence indicate both reactive oxygen species (ROS)
and abnormal mitochondrial activity as probable inciting factors implicated in the deleterious
effects of statins [47–48]. Actually, the inhibition of HMG-CoA reductase that hampers the
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Figure 9. Schematic representation of a costamere and the focal adhesion complex (FAC). Two laminin receptors, a
dystrophin/glycoprotein complex and an integrin receptor complex, are among the sarcolemmal structures that link
the contractile apparatus of muscle fibers with the surrounding basal lamina. Components of both receptors, i.e., both
dystrophin and the integrin-associated cytoskeletal proteins (talin, vinculin, α-actinin), colocalize in subsarcolemmal
complexes which connect through γ-actin and the intermediate-filament proteins desmin and vimentin to the Z-disk of
skeletal muscle fibers, adapted from Patel and Lieber 1997; Rybakova et al., 2000 [138–139], adapted from Fluck et al.
2002 [20].
Importance of Plasma Membrane Nanodomains in Skeletal Muscle Regeneration
http://dx.doi.org/10.5772/60615
mevalonate pathway in addition to impaired cholesterol synthesis also reduces the synthesis
of isoprenoids such as farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate
(GGPP), intermediates affecting number of nonsteroid isoprenoids including coenzyme Q10/
ubiquinone [49], and finally it adversely affects selenoprotein synthesis as well as the biosyn‐
thesis of dolichols, which are involved in the process of protein glycosylation (Figure 10). The
latter mechanism is rate limiting by dolichyl phosphate, which acts as a donor of oligosac‐
charides in glycoprotein synthesis [50]. The importance of glycoproteins in skeletal muscle
growth and regeneration is further emphasized by the examination of N-linked glycoproteome
of C2C12 mouse myoblasts and myotubes [51]. It is clear from this study that approximately
128 (117 transmembrane, 4 glycosylphospatidylinositol-anchored, 5 ECM, and 2 membrane-
associated) proteins were identified, while a few N-linked glycoproteins (including aquapor‐
in-1 and β-sarcoglycan) were apparently of paramount value when myoblasts differentiate to
myotubes. There was an evident decrease of aquaporin-1 and cadherin-2, whereas β-sarco‐
glycan expression level increased as the myoblasts fused and formed multinucleated syncy‐
tium. Ubiquinone is an important electron carrier between the complex I and complex III of
respiratory chain in mitochondria. Thus, decrease in nonsteroid isoprenoids such as CoQ10
leads to the inhibition of complex I, incomplete reduction of oxygen at the level of cytochrome
c oxidase (complex IV), and induces oxidative stress (augmentation of superoxide anion
radical, hydrogen peroxide, and finally hydroxyl radical) postulated to cause myotoxicity of
statins [48]. Myotoxicity is therefore at least in part the consequence of damage to lipids,
proteins, and DNA, although lipids in cellular membranes are most likely targets of ROS
(extensive lipid peroxidation). Additionally, limited access of proteins to prenylation impairs
important lipid anchorages essential for PM attachment and function of a variety of proteins
involved in cell signaling (i.e., heterotrimeric guanine nucleotide-binding protein-coupled
receptors – GPCRs, GTP-binding small/G-proteins Rap1, Ras, Rac, and Rho).
6. LR partners control skeletal muscle regeneration
GPCRs, the most abundant PM receptors, regulate wide range of cellular processes through
intracellular heterotrimeric G protein (GTP-binding protein). The latter acts as a signal
transducer to control the activity of several catalytic proteins central to the message amplifi‐
cation and its intracellular broadening to effector proteins. Heterotrimeric proteins are
composed of three subunits (Gαβγ). Agonist-mediated activation of GPCRs brings about
conformational changes which lead to the exchange of guanosine diphosphate (GDP) for GTP
on the Gα-subunit which then dissociates from Gβγ dimer. Now, Gα may translocate to the
target protein(s), whereas Gβγ dimer inactivates the receptor through phosphorylation (it
recruits G protein–coupled receptor kinase – GRK to inactivate the receptor). As GPCRs
constitute the largest family of membrane receptors, there are at least 16 types of Gα subunits,
5 of Gβ subunits, and 12 types of Gγ subunits [52]. Gα signaling is stopped when GTP is
converted to GDP by the intrinsic GTPase activity of the protein itself. In consequence, Gα-
GDP is reassembled with Gβγ dimer and G-protein complex is reestablished. Importantly,
target proteins for heterotrimeric G-proteins are membrane bound suggesting that lipid–
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protein and/or lipid–lipid interactions are fundamental for G-protein-mediated signaling.
Actually, all known Gγ proteins undergo isoprenylation on cysteine residues (either geranyl‐
geranyl or farnesyl moieties) pointing to increased affinity to hexagonal nonraft phase (e.g.,
PE) of PM [53–54]. In contrast, Gα subunits are modified by myristoylation (Gαi) and/or
reversible palmitoylation (Gα) allowing them to get access to lamellar regions of PM (e.g., lipid
rafts). It also explains how Gα subunits migrate to their cognate targets in LR after dissociation
form Gβγ assembled to GPCRs. Minetti et al. [55] have showed in elegant study that skeletal
muscle hypertrophy and differentiation are greatly influenced by signaling induced by
Figure 10. The biosynthetic pathway of cholesterol and other cometabolites, reprinted from Vaklavas et al. 2009 [58].
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lysophosphatidic acid (LPA) acting on GPCRs which in turn activate a Gαi protein. Besides,
Gαi enhanced muscle regeneration and caused switch to oxidative fibers and can act as a
counterbalance to MuRF1 and MAFbx/atrogin-1. To sum up, lipid structures play active role
in signal propagation with resulting localization of Gα and Gβγ proteins.
Uncommon myopathic changes resultant from statin therapy offer the opportunity to gain
new insight for the function of biochemical pathways downstream to HMG-CoA reductase in
skeletal muscles. Irrespective of the type of statin treatment (hydrophilic or hydrophobic), the
viability of skeletal muscle cells is considerably reduced, though the effect depends largely on
the pharmacokinetic and pharmacodynamic properties of statins [56–57], while the signaling
pathway(s) and molecular mechanisms are still not fully understood. Sometimes, signal
transduction is dependent on small GTPase proteins that cycle between an inactive guanosine
diphosphate (GDP)-bound and active guanosine triphosphate (GTP)-bound state. The
posttranslational prenylation of these proteins occurs by the covalent addition of only two
types of isoprenoids, FPP and GGPP, to cysteine residues at or near the C-terminus. Upon
tyrosine kinase receptor activation, the prenylated (PM protoplasmic/inner leaflet attached)
small GTPase protein Ras (MAPK kinase kinase kinase) binds GTP and becomes activated to
initiate MAPK cascade ending with the stimulation of muscle cell growth (hyperplasia). In
addition, small GTPase protein Rab1 (more than 60 Rab small GTPase isoforms have been
identified) is involved in organelle biogenesis and intracellular vesicular trafficking [58].
Overall growth and survival signals depend on the activation of both protein receptor and
nonreceptor tyrosine kinases.
Several lines of evidence suggest particular significance of IGF-1/PI3-K/AKT cascade in
maintaining muscle cell growth and viability [59–61] likely through the suppression of FOXO-
dependent activity of atrogin/MAFbx ubiquitin ligase gene required for the development of
muscle atrophy [62–63]. Moreover, the statin-induced muscle damage is controlled by
PGC-1α, a transcriptional coactivator that induces mitochondrial biogenesis and protects
against the development of statin-induced muscle atrophy [64]. In in vivo model, simvastatin
downregulated PI3-K/AKT signaling and upregulated FOXO transcription factors and
downstream gene targets known to be implicated in muscle cachexia [63]. Insulin and IGF-1
are widely known agonists of their cognate receptors (IR and IGF-1R, respectively), although
at concentrations higher than physiological cross-reactivity of insulin to IGF-1R and IGF-1 to
IR were observed. On the other hand, LR have been shown to be platforms to initiate cellular
signal transduction of IGF-1 and insulin-inducing skeletal muscle differentiation and hyper‐
trophy. Notably, the impaired insulin/IGF-1 signaling [65–67] mimics the side effects of statin
administration, whereas insulin and/or IGF-1 were reported to overcome statin-induced
myopathy [61]. IR and IGF-1R with their intrinsic tyrosine kinase activities transduce the signal
by recruiting insulin receptor substrate-1 (IRS-1) with its src-homology 2 domains (SH2) to the
receptor phosphotyrosines. IRS-1 activates PI3-K/AKT/mTOR and Ras/Raf/MEK/ERK path‐
ways, however, phosphoinositide 3-kinase (PI3-K) as a lipid kinase converts plasma mem‐
brane phosphatidylinositol-4,5-biphosphate (PIP2) to phosphatidylinositol-3,4,5-triphosphate
(PIP3). The latter attracts kinases with pleckstrin homology domain (PH) downstream to PI3-
K including phosphoinositide-dependent kinase 1 and 2 (PDK1, PDK2) and AKT. Depletion
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of CHOL and sphingolipids blocks IGF-1-induced AKT membrane recruitment, whereas LR
reconstitution in CHOL- and sphingolipid-deficient cells restored AKT membrane recruitment
and phosphorylation [68]. Thus, LR-localized PIP3 is essential for AKT membrane association,
while AKT seems to promote formation of PIP3-containing rafts.
7. Isoprenoids limit skeletal muscle regeneration
While human and animal studies have demonstrated that statin treatment may reduce serum
CoQ10 levels [2, 69], ubiquinone levels in human skeletal muscle do not appear to be affected
by statins [61, 70]. Possible significance of some reactions and intermediates in CHOL synthesis
indicate that GGPP and FPP as isoprene units play very important role in muscle cell survival
and regeneration. The posttranslational prenylation of proteins such as heterotrimeric G
proteins, small G-proteins, and lamins enables these proteins to anchor to cell membranes,
whereas N-linked glycosylation of insulin and IGF-1 membrane receptors mediated by
dolichols establishes their proper biological functions (sensitivity to ligands). Dolichols serve
as carriers and situate the core oligosaccharide to be assembled to protein molecules. From
some studies, it appears that it is mevalonate and isoprene units (GGPP and FPP) as their
downstream intermediates rather than CHOL play the key role in statin-induced myotoxicity.
Consequently, replacement of depleted mevalonate reversed the changes induced by statins,
where squalene synthase or squalene epoxidase (steps in CHOL synthesis) inhibitors at
concentrations sufficient to inhibit entirely CHOL synthesis did not affect muscle cell viability
[71–72]. These observations point to cardinal role played by isoprenoids in physiology of
skeletal muscle cells. Interestingly, statins which are sometimes harm to skeletal muscle cells
do not act adversely on myocardium, a type of striated musculature. Substantial difference in
the sensitivity of skeletal muscle cells and cardiomyocytes to the statin-induced myopathy
could be related to dissimilar mechanisms that control viability of these cells [73]. Alterna‐
tively, it was postulated that Ca2+ homeostasis alterations could account for statin-induced
muscular side effects [74, 75].
8. Ca2+ homeostasis and statin-induced myopathy
Acute application of simvastatin on human skeletal muscle fibers led to a large release of
Ca2+ into the sarcoplasm [76]. The authors showed that mitochondrial Ca2+ efflux through both
permeability transition pores (PTP) and Na+/Ca2+-exchanger (NCE) was a major initiator of the
large sarcoplasmic reticulum (SR) Ca2+ release by affecting ryanodine receptor 1 (RyR1, Figure
11). Furthermore, the effects of simvastatin on Ca2+ homeostasis were not linked to the
disturbed cholesterol synthesis pathway as GGPP and FPP treatments did not prevent statin-
induced Ca2+ waves. They were caused by simvastatin-dependent fall in mitochondrial
membrane depolarization and Ca2+ efflux to the cytoplasm. Next, Ca2+ was recaptured by the
SR that in turn triggered the SR release of Ca2+ by at present unknown molecular mechanism
as “calcium-induced Ca2+ release” is implausible since the main RyR isoform in mammalian
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skeletal muscle is poorly sensitive to Ca2+ [77]. It is apparent from this study that mitochondria
played critical role, and that Ca2+ efflux from mitochondria resulted from alteration of
mitochondrial respiratory chain, as mitochondrial membrane potential (MMP) decreased with
concomitant rise in NADH concentration. Nonetheless, with regard to these experiments some
criticism has to be reserved, as simvastatin concentrations (50–200 μM) were much above the
pharmacological range. Summing up, these observations point to ubiquitin/proteasome (UP)
proteolysis and mitochondria as skeletal muscle target of statins, while the exact nature of their
detrimental action (direct or indirect) remains to be elucidated. Recently, some interesting data
were obtained from transcriptomic analysis of biopsies collected from atorvastatin-treated and
exercised vs. nonexercised skeletal muscles of healthy volunteers. The authors complement
severalfold rise in UP pathway gene expression in 8-hours eccentrically exercised vastus
lateralis muscles baseline compared to the right leg after statin/placebo treatment [78].
Figure 11. A possible direct pathophysiological effect of statins. Although statin myotoxycity may occur through the
reduction of cholesterol synthesis, a direct effect of statins has been reported in vitro and in vivo in muscle fibers from
both animal and human models. This diagram summarizes some of the most recent data suggesting a pathophysiolog‐
ical mechanism. Statins diffuse into muscle fibers and inhibit complex I of the mitochondrial respiratory chain (RC).
This depolarizes the inner membrane (Dc) triggering a calcium release through the permeability transient pore (PTP)
and sodium-calcium exchanger (NCE). This results in a first elevation of cytoplasmic calcium that will be partially up‐
taken by the sarcoendoplasmic reticulum calcium pump (SERCA) to the sarcoplasmic reticulum (SR). When overload‐
ed, SR may spontaneously release calcium through the ryanodine receptor (RyR1) to generate a calcium wave. A direct
effect of statins on RyR1 may not be excluded (dotted line). Impaired mitochondrial function and consequently calci‐
um signaling may account for muscle symptoms, reprinted from Sirvent et al. 2008 [48].
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Deregulation of calcium ion (Ca2+) homeostasis in mitochondria is indicated as initial step in
cascade of events leading to statin myopathy [76, 79]. In several experiments carried out on
C2C12 myoblasts and human muscle biopsies, statins impaired mitochondrial respiration and
sensitized muscle fibers to calcium signaling. Accordingly, muscle fibers showed reduced level
of ATP and higher frequency of Ca2+ waves [46, 79]. Disturbed regulation of Ca2+ homeostasis
(elevated cytoplasmic concentrations) is known to trigger activity of calpains [80], whereas
raise in ROS is associated with caspase cascade [81–82]. As RSC are enriched in SM, they
obviously should have high LR/C representation. Modulation of SL modifications with
sphingomyelinase inhibitors would provide closer look on LR/C impact cell viability/morbid‐
ity. Next to statins widely used as hypocholesteremic drugs, polyunsaturated fatty acids
(PUFA) are frequently recommended to lower blood plasma concentration of low density
lipoproteins (LDL) and triglycerides (TG). There is evidence that PUFA (n–3) synergize with
statins in their positive effect, furthermore some PUFA (EPA and DHA) prevent statin-induced
myopathy [83–84]. It was found that statins evoke endoplasmic reticulum stress (ERS) and ERS
inhibitors as well as PUFA attenuate this response most likely through PPARγ-dependent
mechanism. Detailed outline of PUFA protective effect has, however, not been explained.
Scientific problem is to find out if LR contribute to the activation of RSC. Furthermore, if
LR/C are essential to recruit RSC to enter the differentiation program, what would have been
if LR are ablated? The study aimed to shed more light on the side effects of statin administration
to skeletal muscle is urgently needed. Novelty of research should address etiology to abnormal
function of sarcolemma in skeletal muscle cells of statin-treated subjects. We found only one
report showing that CHOL depletion impaired muscle function [17]. CHOL is essential in
holding together lateral assemblies of lipids in LR nanodomains. The latter are indispensable
to cell signaling as they form platforms for signalosomes (proteins assembled in order to
provide signal transduction from PM receptors). Their role has been corroborated for PI3-
K/AKT and JAK/STAT but not Ras/Raf/MEK/ERK signaling pathway. We assume that former
cascades (PI3-K/AKT and/or JAK/STAT) are involved in RSC activation while the latter are
important to initiate proliferation. As muscle cell differentiation proceeds, the representation
of SL in LR is subjected to additional modifications [85–88]. We guess these changes are related
to the activation of sphingomyelinases and other SL converting enzymes. Ceramides and
sphingosines were reported to frequently affect cell functions including proliferation, differ‐
entiation, and viability [89, 90], and other bioactive lipids are also important players in muscle
growth and regeneration. At the same time, involvement of ROS and mitochondria, Ca2+
homeostasis, and proteolytic systems should be examined.
9. Skeletal muscle satellite cells and LR
Plasma membrane is not uniform in state of matter, i.e., fluid portion is represented by
glycerophospholipids spontaneously mounted into lipid bilayer in disordered manner (Ld –
liquid disordered). As mentioned before, in such membrane, numerous nanodomains known
as lipid rafts contain sphingolipids and CHOL as well as lipid-modified integral membrane
proteins. Nanodomains (Lo – liquid ordered) are buoyant in fluid portion of membrane and
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have tendency to coalesce into larger platforms to form signalosomes essential for signal
transduction [22]. Thus, in muscle cells deprived of mevalonate due to statin administration,
one should expect lower level of LR/C and decreased availability of prenylated proteins
(farnesylated and geranyl-geranylated). It is important to stress that muscle growth, adaptive
hypertrophy, and regeneration are directly attributable to the PM representation of LR
determined by CHOL and sphingolipids [87, 91] found in RSC. The mononucleated RSC are
located beneath the basal lamina that surrounds multinucleated myofibers [6]. They are
activated by signals from injured myofibers and macrophages to enter the cell cycle and
produce myogenic precursor cells that then differentiate and fuse into multinucleated
myotubes or existing myofibers [92]. The molecular mechanisms responsible for the trans‐
duction of such extracellular signals in satellite cells remain poorly defined, and the potential
role of lipid-mediated signaling has not been previously considered in this context. There is
an assumption that satellite cells are capable to rearrange PM composition in order to respond
to extracellular signals and allow cell multiplication and migration which is followed by fusion.
Actually, muscle cells were reported to change the lipid representation in PM according to the
particular step of differentiation [87, 91, 93]. While phosphatidylserine (PS) is highly expressed
during myoblast fusion [88], phosphatidylethanolamine (PE) is involved in cell motility [94].
Both mentioned are the glycerophospholipids of Ld phase located in the protoplasmic leaflet.
On the other hand, sphingomyelin (SM) is found exclusively in the Lo phase where it forms
LR nanodomains with other SL, GSL, CHOL, and proteins. CHOL is essential to organize LR
as it helps both to position SL and GSL and provides the most advantageous energy status
between Lo and Ld phase [95]. Nowadays, it is widely accepted that these nanodomains
facilitate cytoplasmic signaling by acting to concentrate signaling molecules [96]. Additionally,
SL metabolites, such as ceramide, sphingosine, and sphingosine 1-phosphate, are emerging as
important regulators of a variety of cellular events, including cell proliferation, differentiation,
and apoptosis [97–98]. With respect to SM, another important issue is that it is highly repre‐
sented in PM of RSC but during satellite cell proliferation and subsequent differentiation it is
almost undetectable [85]. One has to bear in mind that RSC as being stem cells undergo either
symmetric or asymmetric division and that in the identical culture conditions they adopt
characteristics consistent with a return to quiescent-like state [99]. Thus, it is apparent that
certain activated satellite cells (ASC) by unknown mechanism are withdrawn from the cell
cycle and they escape from the differentiation program. Cell decision whether to differentiate
or not to differentiate is determined by the composition of PM and LR representation in
particular. Under the appropriate conditions, SC differentiate into muscle cells with phenotype
characterized by the accumulation of muscle contractile proteins and increased sensitivity to
insulin. In these differentiated cells, insulin accelerates myogenesis [43]. Insulin initially
stimulates proliferation, and subsequently, it stops cell divisions and stimulates metabolic
pathways to promote protein synthesis. A clear explanation of how these signaling pathways
elaborate such radically different physiological responses in this differentiated tissue has
remained elusive, although compartmentalization and switching-off signaling molecules has
been proposed [43]. Insulin activates their respective tyrosine kinase receptors to phosphory‐
late key residues on a “docking protein” or the receptor, respectively, which recruits multiple
adaptor proteins. Recruited proteins include the GDP exchange factor Son of Sevenless (SOS),
which activates the Ras/Raf/MEK/ERK mitogen-activated protein kinase cascade (mitogenic‐
ity), or the p85 regulatory subunit of PI3-kinase, which stimulates signaling pathways
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ultimately leading to AKT/PKB activation. PI3-K is strongly implicated in metabolic, but not
mitogenic signaling in muscle cells, as is its downstream effector AKT [44]. In the latter paper,
an important role of mitofusin 2 (Mfn2) protein has been shown as a partner and inhibitor of
Ras. Thus, it become clear why studying the ability of different approaches to regulate
numerous signaling molecules, statins and CHOL chelators, particularly PI3-K and AKT (PI3-
K/AKT), are essential due to their relevance to anabolic metabolism in myotubes and LR
reliance. Comparative studies concerning Ras/Raf/MEK/ERK and JAK/STAT would be crucial
as these pathways are involved in muscle cell proliferation and they compromise muscle
differentiation [100]. It is not clear if reactive oxygen species (ROS) are involved as a cause or
an effect of disturbance [46, 79, 101]. Lower production of ATP would explain faster muscle
fatigue observed during exercise in statin-induced myopathy [102]. Interestingly, appropriate
muscle exercise (physical training) might protect skeletal muscles from undesired statin-
induced side effects [103]. This is of particular importance as the widespread use of statins and
more active lifestyle might foster the incidence of SIM.
10. Heat controls vital signaling molecules in plasma membrane
Although the molecular mechanisms that regulate the differentiation of satellite cells and
myoblasts toward myofibers are not fully understood, cell membrane lipids and proteins that
sense and respond to their environment must play an important role. Heat alters PM physical
state into more fluidic form, and similar effect may be artificially induced by membrane
fluidizers [104]. Interestingly, heat-induced hyperfluidization in animal PM is associated with
the activation of the cholesteryl glucoside (CG) synthetase (glucosyltransferase) located in LR,
the enzyme that catalyzes the transfer of the glucose moiety from glucose donor sphingolipid
glucosylceramide to cholesterol [105]. CG production alters membrane physical properties and
forms thermostable solid-ordered domains. Notably, CG and other steryl glucosides act as
important lipid mediators in the process of heat shock factor-1 (HSF-1) activation. This
transcription factor regulates the expression of heat shock proteins (HSPs), which are critical
for the survival of cells [104]. Some authors showed that the alteration of membrane fluidity
by heat or membrane fluidizer treatment causes the reorganization of lipid rafts linked to
activation of heat shock response mediated by HSF-1 activation and HSP induction [106–108].
It is suggested by Kunimoto et al. [110–111] that PM fluidity leads to CG formation and the
latter mediates HSF-1 activation and HSP induction. There is growing body of evidence that
strategies aimed at increasing levels of HSPs may be successful in protecting cells in neuro‐
degenerative diseases. At least in the animal model of amyotrophic lateral sclerosis (ALS),
increasing HSP levels by treatment with arimoclomol (hydroxylamine derivative) delayed
disease progression in mice [112, 113]. Another hydroxylamine derivative, namely, BGP-15
inhibited acetaminophen-induced caspase-independent apoptosis of hepatocytes [106]. The
prime HSPs induced by heat stress or membrane fluidizers are HSP70 and HSP90. Importantly,
HSP72 preserves muscle function and slows progression of severe muscular dystrophy [114].
Under normal circumstances, chaperone proteins involved in protein quality control can
prevent protein aggregation by binding of misfolded proteins as soon as they are produced
during translation or later during their organization into supramolecular structures, thereby
assisting protein refolding or else in targeting for degradation [115].
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11. Sphingolipids in skeletal muscle regeneration
Sphingolipids (SL) and cholesterol (CHOL) create LR in plasma membrane, but it is the
biochemistry of SL that is apparently decisive for skeletal muscle biology including its growth
and differentiation. PM sphingomyelin is a target for both acidic and neutral sphingomyeli‐
nases (aSMase and nSMase) bringing ceramide (Cer) as product. Ceramides are LR modulators
believed to alter PM fluidity and favor receptor oligomerization [116]. Cer has been suggested
to fulfill a second-messenger function but the evidence for this action is scarce and controver‐
sial, while support is emerging for its indirect impact on cellular signaling resulting from
changes in membrane structure. Cer could be further converted to sphingosine by ceramidase,
whereas sphingosine 1-phosphate is synthesized from sphingosine by a phosphorylation
reaction catalyzed by the sphingosine kinases (SKs) SK1 and SK2, which are highly conserved
enzymes activated by numerous stimuli including transactivation induced by IGF-1 [117].
From studies carried out on C2C12 myoblast cell line as progeny of mouse satellite cells, it is
clear that IGF-1 evokes two mutually exclusive biological responses (hyperplasia vs. hyper‐
trophy). This cytokine plays a key role in skeletal muscle regeneration as it is able to recruit
satellite cells and stimulate myoblast proliferation and myogenic differentiation. As mentioned
before, myoblasts must not fuse unless they are withdrawn from the cell cycle. How then,
IGF-1 regulates two opposite responses? In recent years, the sphingosine 1-phosphate (S1P)
attracts special attention with regard to physiology of resident skeletal muscle satellite cells as
well as proliferating and differentiating myoblasts. First, several lines of evidence indicate
significant role of S1P in skeletal muscle regeneration and repair [85, 117–122]. The extracel‐
lular action of S1P present in micromolar concentrations in peripheral blood is exerted by
binding to five specific cell surface heterotrimeric G protein–coupled S1P receptors (S1P1–
S1P5). In turn, S1P agonist levels are tightly controlled by the balance between biosynthesis
catalyzed by SKs, reversible conversion to sphingosine mediated by specific and nonspecific
lipid phosphatases, and S1P lyase (SPL)-dependent degradation. Second, S1P receptors are
coupled to one or more G-proteins so they can elicit distinct and even contrasting final cellular
effects (Figure 12). In skeletal muscle cells, major role is played by S1P1, S1P2, and S1P3 receptors
[117, 119–122]. Actually, in myoblasts, S1P1 and S1P3 receptors via SK activation negatively
regulate the mitogenic effect elicited by IGF-1, whereas S1P2 receptor is involved in myogenic
effect of the growth factor (Figure 13). Thus, in myoblasts, SK/S1P axis upon IGF-1 action
regulates two opposing biological effects – transducing its myogenic response on one side and
inhibiting its mitogenic effect on the other. The IGF-1-dependent transactivation of S1P
receptors was also observed in other cell types pointing to the conservation of the
IGF-1/SK/S1P circuit in tissues other than skeletal muscle [123]. How IGF-1 does affect SKs
leading to two divergent biological effects in skeletal muscle? Among the various signaling
pathways activated by S1P in skeletal muscle cells, the activation of ERK1/2 and p38 MAPK,
both identified as downstream effectors of S1P2 in response to growth factors, was required
for cell proliferation and the stimulation of myogenic differentiation, respectively [124]. The
inhibition of ERK1/2 activity with specific U0126 metabolic inhibitor prevented SK1 phos‐
phorylation induced by IGF-1, demonstrating that the activation of SK1 induced by the growth
factor was mediated by ERK1/2 [116]. Similarly, the S1P-induced differentiation was prevented
Muscle Cell and Tissue128
in myoblasts where p38 MAPK was inactivated by the overexpression of the dominant
negative mutant or by the use of specific p38 MAPK inhibitors SB203580 and SB239063 [118].
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Figure 12. Role of sphingosine 1-phosphate on cell proliferation and migration in myoblasts and activated satellite
cells, adapted from Donati et al. 2013 [125].
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Figure 13. Schematic diagram of the biological actions evoked by S1PR transactivation by some growth factors in
C2C12 myoblasts, adapted from Donati et al. 2013 [125].
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One has to keep in mind, however, that S1P receptors are differently expressed in satellite cells,
myoblasts, and muscle fibers, moreover their expression may vary in response to the action of
particular factor. PDGF stimulates myoblasts proliferation and motility, while these effects are
blocked by SK1/S1P1 signaling axis [126]. In contrast, TGF-β1 was demonstrated to convey its
detrimental profibrotic effect through S1P3 receptors (Figure 13) [127]. These observations
complement widely known activities of PDGF and TGF-β1 in wound healing. In the second
intention healing as it is observed in the severe skeletal muscle injury or late stages of myo‐
pathy, the major role is played by myofibroblasts which cause fibrosis, a hallmark of in which
myofibers are replaced by progressive deposition of extracellular matrix proteins [128]. The
main task is therefore to facilitate skeletal muscle regeneration rather than repair, as the first
one restores tissue structure and contractile function while the latter is limited to structural
return. There are efforts observed to improve muscle healing by regeneration rather than
fibrosis [129]. Collectively, taking into account the knowledge on how sphingosine 1-phos‐
phate influences RSC and how it might prevent muscle fibrosis, it will be interesting to further
investigate in this context the crosstalk between IGF-1 and S1P signaling pathway.
12. Concluding remarks
Primary stem cells in adult skeletal muscle known as satellite cells drive postnatal muscle
growth and regeneration-associated hypertrophy. They reside beneath the basal lamina of the
myofibers suggesting close contact between the adjacent cytoskeletons and chemical commu‐
nication between the cells. One of the major unexplored areas of satellite cell biology is the
identification of signals that are conferred from adjacent myofibers and the surrounding
extracellular matrix. Equally important are soluble endocrine, paracrine, and autocrine factors
that maintain satellite cells quiescent and control their preference to activate. For example, the
maintenance of skeletal muscle requires notch signaling and greatly depends on delta
upregulation for RSC activation [130]. In addition to the loss of notch activation, nonregener‐
ating skeletal muscle produces excessive transforming growth factor (TGF)-β (but not
myostatin), which induces unusually high levels of TGF-β pSmad3 and interferes with their
regenerative capacity [131]. Thus a balance between endogenous pSmad3 and active notch
controls the regenerative competence of muscle stem cells, and the deregulation of this balance
in the old muscle microniche interferes with regeneration. The molecular mechanisms that
regulate satellite cell quiescence, activation, and self renewal (asymmetric divisions) are not
well understood, even though a possible clue for the ambiguous behavior of satellite cells could
be associated with the membrane segregation of rafts and bioactive lipids such as PS that seems
to accelerate myoblasts fusion into myotubes [132]. It seems plausible to affirm sarcolemmal
differentiation as the leader constituent of stimulated skeletal muscle progenitors and subse‐
quent populations of daughter cells (myoblasts, myotubes, and juvenile myofibers) involved
in myogenic program. Lipid moiety of plasma membrane is not merely a boundary or the
component in intercellular communication. Nowadays, it is widely accepted that specific lipids
associate to form functional units (LR/C), creating substructures that actively modify its own
composition including proteins and triggering a myriad of different signaling pathways. Lipid
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segregation seems to account for the adaptability of skeletal muscle to a variety of stimuli,
where the critical role is played by the myogenic signals represented by growth factors and
cytokines. Cholesterol, isoprenoids, dolichols, and sphingolipids all contribute significantly to
the physiological responses of skeletal muscle to injury. These bioactive lipids mediate most,
if not all, of the signals elicited at the plasma membrane receptors. Recent advances in muscle
research suggest key position occupied by sphingosine 1-phosphate, protein prenylation, and
“caveolar” and “noncaveolar rafts” in skeletal muscle regeneration process.
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